Stephens downgraded ArcBest (ARCB) to Equal Weight from Overweight with a price target of $72, down from $99. While the firm believes Q4 guidance has temporary headwinds embedded, its also thinks the recovery to LTL volumes and mix could be longer to play out than the firm had originally expected. While it continues to like the long-term story, the near term valuation “seems full” and the firm is awaiting signs of a more meaningful volume recovery within LTL before becoming more positive, the analyst tells investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB:
